Safety and efficacy of TNFα blockade in relapsing vasculitis
Open Access
- 1 June 2002
- journal article
- letter
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 61 (6) , 559
- https://doi.org/10.1136/ard.61.6.559
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Effect of infliximab on sight-threatening panuveitis in Behcet's diseaseThe Lancet, 2001
- Etanercept combined with conventional treatment in Wegener's granulomatosis: A six-month open-label trial to evaluate safetyArthritis & Rheumatism, 2001
- Isolated digital vasculitis in a patient with rheumatoid arthritis: good response to tumour necrosis factor α blocking treatmentAnnals of the Rheumatic Diseases, 2001
- Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trialThe Lancet, 1999
- A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's DiseaseNew England Journal of Medicine, 1997